July 18, 2025 – Talk Bio

Actionable Insights Powered by AI

BioNTech Chief Strategy Officer Departs Amid Oncology Pivot and Major Deals

12 hours ago talkbio0Tagged BioNTech, cancer pipeline, CureVac acquisition, Leadership, oncology pivot, Ryan Richardson

BioNTech; chief strategy officer; Ryan Richardson; oncology pivot; CureVac acquisition; cancer pipeline; leadership transition

Kowa Secures Expanded Rights to Nicox’s Glaucoma Drug NCX 470 in Major Global Deal

17 hours ago talkbio0Tagged Clinical Trials, Denali, Glaucoma, Kowa, licensing agreement, milestone payments, naproxen-n-butyl nitrate, Ophthalmology specialty, royalties, TLX2 gene

Kowa; Nicox; NCX 470; glaucoma; exclusive rights; licensing agreement; Denali clinical trial; ophthalmology; royalties; milestone payments